Cocrystal Pharma Moves Lower as Norovirus Program Draws Fresh Attention
Cocrystal Pharma fell to $1.11 in thin volume Thursday as the market looked for new updates from the company’s norovirus drug work. Shares changed hands between $1.09 and $1.11. The SPDR S&P Biotech ETF was also a touch lower. COCP’s move is notable. The stock trades as a micro-cap, with its market value at about $15.3 million as of the latest quote. Fewer than 20,000 shares traded, so small orders can swing the price sharply and old news can hit harder.